Cargando…
Efficacy and Safety of Anti–Nerve Growth Factor Antibody Therapy for Hip and Knee Osteoarthritis: A Meta-analysis
BACKGROUND: The efficacy and safety of anti–nerve growth factor (NGF) antibody therapy used for osteoarthritis (OA) pain are controversial. PURPOSE: To evaluate the efficacy and safety of anti-NGF antibody therapy via a meta-analysis of randomized controlled trials (RCTs). STUDY DESIGN: Systematic r...
Autores principales: | Gao, Yijie, Hu, Zhengxu, Huang, Yi, Liu, Weijian, Ren, Changle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047886/ https://www.ncbi.nlm.nih.gov/pubmed/35494494 http://dx.doi.org/10.1177/23259671221088590 |
Ejemplares similares
-
Efficacy of nerve growth factor antibody in a knee osteoarthritis pain model in mice
por: Miyagi, Masayuki, et al.
Publicado: (2017) -
Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis
por: Birbara, Charles, et al.
Publicado: (2018) -
Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects
por: Gow, Jason M., et al.
Publicado: (2015) -
Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis
por: da Costa, Bruno R, et al.
Publicado: (2021) -
Efficacy and safety of sprifermin injection for knee osteoarthritis treatment: a meta-analysis
por: Zeng, Ni, et al.
Publicado: (2021)